Aaspada Enterprises Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -100.00%
- Profit Growth -18970.74%
- Ebitda -55.65%
- Net Worth -224.36%
- Total Assets -31.45%
About Aaspada Enterprises
Aaspada Enterprises Private Limited (AEPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 April 2015 (Nine years and nine months 28 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sanal Kuttikkat, Nyapati Giridhar, and Asis Behera serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74900DL2015PTC279275
-
Company No.
279275
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Apr 2015
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Aaspada Enterprises?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nyapati Giridhar
|
Director | 20-Apr-2015 | Current |
|
Sanal Kuttikkat
|
Director | 20-Apr-2015 | Current |
|
Asis Behera
|
Director | 20-Apr-2015 | Current |
Financial Performance of Aaspada Enterprises.
Aaspada Enterprises Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial fall in profitability, with a 18970.74% decrease in profit. The company's net worth observed a substantial decline by a decrease of 224.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aaspada Enterprises?
Unlock access to Aaspada Enterprises's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Saisun Pharma Private LimitedSanal Kuttikkat and Nyapati Giridhar are mutual person
-
Erotas Life Sciences Private Limited
Nyapati Giridhar and Asis Behera are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aaspada Enterprises?
Unlock and access historical data on people associated with Aaspada Enterprises, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aaspada Enterprises, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aaspada Enterprises's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
